Clinical Trial Update: Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer

View source ↗

Summary

GlaxoSmithKline-sponsored cross-sectional study on HPV type distribution in adult women diagnosed with cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Uterine Cervix, Cervical Cancer | Status: COMPLETED